Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 17 drugs
| No. | DrugBank | Drug (Description in trials) | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ubenimex | [1] Ubenimex Ubenimex | [1] Ubenimex
Ubenimex
💬1. Ubenimex
| [1] ANPEP ANPEP 💬1. Ubenimex
| [4] Glutathione metabolism Glutathione metabolism, Hematopoietic cell lineage, Metabolic pathways, Renin-angiotensin system 💬 [4] Glutathione metabolism, Hematopoietic cell lineage, Metabolic pathways, Renin-angiotensin system ... | [1] 86 86 💬1. Ubenimex
| ||||||||||||||||||||||||||||||
| 2 | Ubidecarenone | [3] Coenzyme Q-10 Coenzyme Q-10; Coenzyme Q10; CoQ10 | [1] Ubidecarenone
Ubidecarenone
💬2. Ubidecarenone
| - | - | [12] 2 2, 5, 6, 8, 10, 18, 46, 57, 86, 113, 214, 215 💬2. Ubidecarenone
| ||||||||||||||||||||||||||||||
| 3 | Ubiquinol | [1] Ubiquinol Ubiquinol | - | - | - | [3] 6 6, 8, 17 💬
| ||||||||||||||||||||||||||||||
| 4 | Ublituximab | [1] UBLITUXIMAB UBLITUXIMAB | [1] Ublituximab
Ublituximab
💬4. Ublituximab
| [1] MS4A1 MS4A1 💬4. Ublituximab
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬4. Ublituximab
| ||||||||||||||||||||||||||||||
| 5 | Udenafil | [1] Udenafil Udenafil | [1] Udenafil
Udenafil
💬5. Udenafil
| [1] PDE5A PDE5A 💬5. Udenafil
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 86 86, 210 💬
| ||||||||||||||||||||||||||||||
| 6 | Ularitide | [1] ULARITIDE ULARITIDE | - | - | - | [1] 86 86 💬6. Ularitide
| ||||||||||||||||||||||||||||||
| 7 | Ulipristal | [1] Ulipristal Ulipristal | [1] Ulipristal
Ulipristal
💬7. Ulipristal
| [1] PGR PGR 💬7. Ulipristal
| [5] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte ... | [1] 10 10 💬7. Ulipristal
| ||||||||||||||||||||||||||||||
| 8 | Undecanoic acid | [1] Undecanoate Undecanoate | - | - | - | [2] 13 13, 60 💬
| ||||||||||||||||||||||||||||||
| 9 | Unoprostone | [1] Unoprostone Unoprostone | [1] Unoprostone
Unoprostone
💬9. Unoprostone
| [1] PTGFR PTGFR 💬9. Unoprostone
| [3] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬 [3] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pa ... | [1] 90 90 💬9. Unoprostone
| ||||||||||||||||||||||||||||||
| 10 | Upadacitinib | [2] Rinvoq Rinvoq; Upadacitinib | [1] Upadacitinib
Upadacitinib
💬10. Upadacitinib
| [1] JAK1 JAK1 💬10. Upadacitinib
| [27] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 [27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus i ... | [8] 40 40, 41, 46, 49, 96, 97, 107, 271 💬
|